UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021450
Receipt number R000024738
Scientific Title Densitometry of Choroidal Vessels by Wide-Field Indocyanine Green Angiography
Date of disclosure of the study information 2016/03/14
Last modified on 2023/03/18 17:24:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Densitometry of Choroidal Vessels by Wide-Field Indocyanine Green Angiography

Acronym

Choroidal Vessel Densitometry

Scientific Title

Densitometry of Choroidal Vessels by Wide-Field Indocyanine Green Angiography

Scientific Title:Acronym

Choroidal Vessel Densitometry

Region

Japan


Condition

Condition

Healthy eyes and eyes with central serous chorioretinopathy, Harada's disease, diabetic retinopathy, age-related macular degeneration, etc

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To develop a new method to quantify the choroidal vessel density by binarizing ultra-wide-field indocyanine green angiography (ICGA) images and determine whether values are altered in diseased eyes.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Repeatability of densitometry

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

healthy eyes and eyes with central serous chorioretinopathy, diabetic retinopathy, Harada's disease, age-related macular degeneration, etc

Key exclusion criteria

Patients with hypertension, and hypercholesterolemia that could affect ocular circulation, and high myopia (defined as SERE in phakic eyes < -8.0 D)

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Tsutomu
Middle name
Last name Yasukawa

Organization

Nagoya City University Graduate School of Medical Science

Division name

Department of Ophthalmology and Visual Science

Zip code

467-8601

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JAPAN

TEL

052-853-8251

Email

yasukawa@med.nagoya-cu.ac.jp


Public contact

Name of contact person

1st name Tsutomu
Middle name
Last name Yasukawa

Organization

Nagoya City University Graduate School of Medical Science

Division name

Department of Ophthalmology and Visual Science

Zip code

467-8601

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JAPAN

TEL

0528538251

Homepage URL


Email

yasukawa@med.nagoya-cu.ac.jp


Sponsor or person

Institute

Nagoya City University Graduate School of Medical Science

Institute

Department

Personal name



Funding Source

Organization

Nagoya City University Graduate School of Medical Science

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya City University Graduate School of Medical Sciences

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku

Tel

0528538251

Email

yasukawa@med.nagoya-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 14 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

40

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2015 Year 04 Month 01 Day

Date of IRB

2015 Year 05 Month 01 Day

Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study design: Case control series
Enrollment: all eligible patients visiting Nagoya City University since May 2015


Management information

Registered date

2016 Year 03 Month 12 Day

Last modified on

2023 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024738


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name